Ying Cui | Immunology and Microbiology | Excellence in Research Award

Published on by Forensic Scientist

Ms. Ying Cui | Immunology and Microbiology | Excellence in Research Award

Beijing Friendship Hospital, Capital Medical University | China

Ms. Ying Cui is an emerging neuroscientist whose research advances the understanding of the gut–brain axis, neurodegeneration mechanisms, and biomarker innovation in Parkinson’s disease (PD). Her work integrates metagenomics, multi-parameter clinical imaging, molecular neuroscience, and machine-learning analytics to improve diagnostic precision and support translational therapeutic development. With 6 Scopus-indexed publications, 85 citations, and an h-index of 2, her research impact continues to grow across both clinical and experimental domains. Ms. Ying Cui has contributed to high-value research projects, including multicenter clinical trials and national-level neuroscience studies, where she played key roles in microbiome profiling, experimental methodology, and advanced neuroimaging assessment using ¹²³I-MIBG scintigraphy. Her first-author publications provide novel insights into the diagnostic performance of cardiac and extra-cardiac washout rate parameters for differentiating PD from Parkinson-plus syndromes, offering clinically relevant imaging markers for complex diagnostic scenarios. Complementing her imaging research, Ying has developed a high-accuracy metagenomic diagnostic model with 99% validation accuracy and identified functional probiotic strains with the potential to modulate α-synuclein aggregation, mitochondrial dysfunction, and neuroinflammatory signaling work that has led to a PCT international patent for a probiotic composition targeting REM Sleep Behavior Disorder. Her multidisciplinary contributions span biomarker discovery, clinical–computational integration, translational microbiome innovation, and cross-institutional collaborations in neurology, microbiology, metabolomics, and bioinformatics. Through this synergistic research portfolio, Ying Cui continues to advance early diagnostic strategies, mechanistic insights, and therapeutic innovation in Parkinson’s disease, establishing herself as a rising researcher in translational neurodegeneration science.

Profiles: Scopus | ORCID

Featured Publications

  • Xue, T., Cui, Y., Kan, Y., & Yang, J. (2025). Value of extra-cardiac sympathetic nervous uptake parameters based on ¹²³I-MIBG SPECT/CT in the assessment of Parkinson’s disease. Clinical and Translational Imaging.

  • Xue, T., Cui, Y., Kan, Y., & Yang, J. (2025). Value of multi-parameter ¹²³I-MIBG scintigraphy in the differential diagnosis of Parkinson’s disease. EJNMMI Research.

Yuyan Tang | Immunology and Microbiology | Best Researcher Award

Published on by Forensic Scientist

Prof. Yuyan Tang | Immunology and Microbiology | Best Researcher Award

Minhang Hospital, Fudan University | China

Prof. Yuyan Tang is a clinician-scientist specializing in nephrology and molecular immunopathology, with a strong research focus on the gut–kidney axis, IgA nephropathy, and chronic kidney disease (CKD). Her studies elucidate the mechanisms by which intestinal microbiota, short-chain fatty acids (SCFAs), and NLRP3 inflammasome signaling influence renal inflammation and fibrosis, integrating molecular biology with traditional Chinese medicine interventions. She has led several competitive research projects funded by the National Natural Science Foundation of China and regional scientific bodies, advancing translational insights into renal disease mechanisms and microbiome-based therapeutic strategies. Prof. Yuyan Tang has published 23 peer-reviewed documents indexed in Scopus, garnering 287 citations across 262 citing documents, with an h-index of 8. Her scientific contributions include 8 first- or corresponding-author SCI papers with a total impact factor of 52.7, notably featuring a highly cited article in Circulation Research and impactful publications in Nephrology Dialysis Transplantation and BMC Microbiology. Recognized as a Youth Talent Awardee at Fudan University’s Affiliated Minhang Hospital, Prof. Yuyan Tang’s research continues to bridge microbiome regulation and nephrology through innovative molecular and clinical investigations.

Profile: Scopus

Featured Publications

  • Tang, Y., Zhu, Y., He, H., Sun, W., Wu, J., Xiao, Y., … Xu, X. (2024). IgA nephropathy: Gut microbiome regulates the production of hypoglycosylated IgA1 via the TLR4 signaling pathway. Nephrology Dialysis Transplantation, 39(10), 1624–1641.

  • Jiang, L., He, H., Tang, Y., Li, J., Reilly, S., Xin, H., … Cai, H. (2024). Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca2+ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy. Autophagy, 20(11), 2388–2404.

  • Li, H., Xu, M., Xu, X., Tang, Y., Jiang, H., Li, L., … Yang, T. (2022). Faecalibacterium prausnitzii attenuates CKD via Butyrate-Renal GPR43 Axis. Circulation Research, 131(9), e120–e134.

  • Tang, Y., Xiao, Y., He, H., Zhu, Y., Sun, W., Hu, P., … Xu, X. (2023). Aberrant gut microbiome contributes to barrier dysfunction, inflammation and local immune responses in IgA nephropathy. Kidney and Blood Pressure Research, 48(1), 261–276.

  • Tang, Y., Zhu, Y., He, H., Peng, Y., Hu, P., Wu, J., … Xu, X. (2022). Gut dysbiosis and intestinal barrier dysfunction promote IgA nephropathy by increasing the production of Gd-IgA1. Frontiers in Medicine, 9, 944027.

Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Published on by Forensic Scientist

Mrs. Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University | Poland

Mrs. Monika Prylińska-Jaśkowiak is an emerging clinician-scientist whose professional journey reflects a rare balance between medical practice, academic excellence, and translational research. She earned her Doctor of Medical Sciences degree from Collegium Medicum, Nicolaus Copernicus University in Toruń, where her doctoral research focused on the relationship between the gut microbiome and chronic fatigue syndrome, integrating clinical insight with advanced molecular and bioinformatic analyses. As a specialist pediatrician at the Voivodeship Children’s Hospital in Bydgoszcz, she combines her research background with everyday patient care and is currently pursuing specialization in pediatric rheumatology. Her scientific contributions include peer-reviewed publications such as The gut microbial composition is different in chronic fatigue syndrome than in healthy controls (Scientific Reports, 2025), and review papers in the Journal of Education, Health and Sport (2022), widely cited for summarizing current knowledge on CFS/ME and human gut microbiota. Mrs. Monika Prylińska-Jaśkowiak’s research interests encompass pediatric immunology, microbiome–immune interactions, and chronic inflammatory diseases, with a focus on precision diagnostics and targeted therapy development. Actively engaged in professional societies including the Polish Pediatric Society and the Polish Society of Vaccinology, she continues to expand her expertise through certified courses in resuscitation, vaccinology, and emergency pediatrics. Her commitment to continuous learning, clinical excellence, and evidence-based innovation exemplifies the spirit of a modern physician-scientist dedicated to improving child health and advancing medical science.

Profile: ORCID | LinkedIn

Featured Publications

• Prylińska, M., & Kożuchowski, M. (2022, September 28). The human gastrointestinal tract microbiota in health – current knowledge summary. Journal of Education, Health and Sport, 12(10). https://doi.org/10.12775/JEHS.2022.12.10.005

• Kożuchowski, M., & Prylińska, M. (2022, April 30). The proper functioning of the sense of smell and its disturbances on the example of COVID-19 infection. Journal of Education, Health and Sport, 12(4). https://doi.org/10.12775/JEHS.2022.12.04.026

Majid Taati Moghadam | Immunology and Microbiology | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Majid Taati Moghadam | Immunology and Microbiology | Best Researcher Award

Guilan University of Medical Sciences | Iran

Dr. Majid Taati Moghadam is a dedicated Medical Microbiologist and Antimicrobial Resistance Researcher based in Rasht, Iran. He specializes in microbial pathogenesis, antibiotic resistance mechanisms, bacteriophage therapy, and the connection between microbiota and neurodegenerative disorders. His multidisciplinary expertise extends across clinical microbiology, infectious disease prevention, and translational therapeutics, making him a leading figure in Iran’s microbiological research community.

Professional Profile

Scopus

Google Scholar

ORCID

Education

Dr. Majid Taati holds a Ph.D. in Medical Bacteriology from Iran University of Medical Sciences (2017–2022), where his research investigated the relationship between oral microbiome shifts and Alzheimer’s disease. He earned his Master’s degree in Medical Microbiology from Kerman University of Medical Sciences (2012–2015), focusing on carbapenem resistance genes in Klebsiella pneumoniae. His academic journey began with a Bachelor’s degree in Microbiology from Islamic Azad University, Lahijan Branch (2007–2012). Throughout his studies, he demonstrated a keen interest in antibiotic resistance, clinical diagnostics, and the molecular biology of pathogens.

Experience

Dr. Majid Taati has played key roles in over a dozen microbiological research projects across Iran. As both a principal investigator and main collaborator, he has contributed to studies on extended-spectrum beta-lactamase (ESBL) genes, resistance enzymes in E. coli, and the antimicrobial effects of plant extracts like Ephedra pachyclada. He has worked extensively on projects involving nosocomial infections, multidrug-resistant bacteria, and genetic analysis methods such as MLVA and HRM techniques. He also authored the textbook Essential Medical Microbiology in Persian, and presented his findings at several major Iranian congresses, including the International Microbiology Congress. His laboratory and academic experience bridges both applied research and educational leadership.

Research Interests

Dr. Majid Taati research focuses on antimicrobial resistance mechanisms, phage and endolysin therapy, bacterial biofilm inhibition, and engineered phage enzymes for resistant infections. He is also deeply involved in exploring the role of microbiota in neurological and neuropsychiatric disorders, especially Alzheimer’s disease. His studies aim to bridge clinical microbiology with therapeutic innovation addressing global health threats posed by superbugs like carbapenem- and colistin-resistant Gram-negative bacteria. His recent projects extend to wound healing biomaterials, phage protein therapies, and microbiome-based diagnostics, reflecting his broad and multidisciplinary scientific interests.

Awards

Recognized for his extensive research contributions, Dr. Majid Taati is a deserving nominee for the “Best Researcher Award” in medical microbiology and antimicrobial resistance. His scholarly excellence, particularly in phage therapy and resistance gene profiling, aligns well with the objectives of scientific bodies that honor groundbreaking research. With dozens of publications in top-tier journals and continuous involvement in nationally significant projects, he exemplifies leadership in translational microbiology and global infectious disease research.

Publications

  • Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
    Year: 2020
    Citations: 316

  • Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
    Year: 2020
    Citations: 311

  • How phages overcome the challenges of drug resistant bacteria in clinical infections
    Year: 2020
    Citations: 173

  • Bacteriophages, a new therapeutic solution for inhibiting multidrug-resistant bacteria causing wound infection: lesson from animal models and clinical trials
    Year: 2020
    Citations: 125

  • COVID-19 (Coronavirus disease 2019): a new coronavirus disease
    Year: 2020
    Citations: 108

  • Evaluation of Nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from clinical samples
    Year: 2019
    Citations: 108

  • Bacteriophage as a novel therapeutic weapon for killing colistin-resistant multi-drug-resistant and extensively drug-resistant gram-negative bacteria
    Year: 2021
    Citations: 58

Conclusion

Dr. Majid Taati Moghaddam Ziabari has built an impressive career defined by scientific innovation, deep academic rigor, and a commitment to combating infectious diseases. His pioneering work in bacteriophage therapy and antimicrobial resistance not only advances microbiological science but also addresses some of the most urgent global health challenges. With his rich publication record, research leadership, and academic influence, he is a prime candidate for international recognition, especially the Best Researcher Award. His career serves as a model of excellence in translational research and academic impact.

Viviana Cafiso | Immunology | Excellence in Research

Published on by Forensic Scientist

Assoc. Prof. Dr. Viviana Cafiso | Immunology | Excellence in Research

University of Catania | Italy

Prof. Viviana Cafiso, born in Caltagirone on October 1, 1971, is a renowned Associate Professor of General Microbiology at the University of Catania, Italy. With decades of experience in clinical microbiology and antimicrobial resistance research, she has significantly contributed to understanding infectious diseases through molecular and omics-based approaches. Her work bridges experimental and translational science, impacting public health and clinical strategies across Europe.

Author Profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Prof. Viviana Cafiso demonstrates an exceptional track record in microbiological research with a specific focus on antimicrobial resistance, bacterial genomics, and biofilm biology. Her prolific publication record — with nearly 40 high-impact articles in internationally indexed journals such as Antibiotics, Frontiers in Microbiology, Pathogens, PLoS One, and Clinical Microbiology and Infections — underscores her scholarly impact. Several of her articles have significant citation counts and address global health concerns like multidrug-resistant pathogens and hospital-acquired infections.

Additionally, her involvement in major national and international projects, including the PNRR INF-ACT, SMART and ATLAS projects (in partnership with Merck and Pfizer), and the PRIN and PON programs, confirms her leadership and collaboration in interdisciplinary consortia. Her position as Associate Professor of General Microbiology and a Ph.D. board member in Biomedical Sciences highlights her ongoing contributions to mentoring the next generation of researchers.

Moreover, her active role in molecular microbiology education across various degree levels reflects her holistic commitment to science dissemination, both in research and academia.

🎓 Education

Prof. Cafiso has pursued rigorous academic training in microbiology, culminating in her doctoral studies which laid the foundation for her specialization in antimicrobial resistance. Her academic trajectory reflects a deep-rooted commitment to molecular diagnostics and microbial genomics.

👩‍🏫 Experience

Prof.ssa Cafiso currently serves at the Department of Biomedical and Biotechnological Sciences, University of Catania, teaching Microbiologia Molecolare Applicata, Scienze Omiche, and other microbiology-focused subjects across undergraduate and postgraduate programs. She has also served as Scientific Coordinator and Principal Investigator in national and international microbiological research projects.

🔍 Research Interests On Immunology

Her primary research interests include antimicrobial resistance mechanisms, omics technologies, bacterial genomics, pathogen virulence, biofilm formation, and molecular epidemiology. She has played pivotal roles in numerous projects such as INF-ACT, PRIN PNRR, ARISE, and collaborations with pharmaceutical giants like Pfizer and Merck.

🏅 Awards & Recognitions

While her academic biography primarily emphasizes her research achievements, Prof.ssa Cafiso’s consistent participation in high-profile funded projects and collaborations with international research networks highlights her recognition as a leading figure in microbiology and translational infectious disease research.

📚 Publications

  • Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production
    Authors: V. Cafiso, T. Bertuccio, M. Santagati, F. Campanile, G. Amicosante, …
    Year: 2004
    Citations: 214

  • Essential oils encapsulated in polymer-based nanocapsules as potential candidates for application in food preservation
    Authors: G. Granata, S. Stracquadanio, M. Leonardi, E. Napoli, G.M.L. Consoli, …
    Year: 2018
    Citations: 163

  • agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus
    Authors: V. Cafiso, T. Bertuccio, M. Santagati, V. Demelio, D. Spina, G. Nicoletti, …
    Year: 2007
    Citations: 143

  • Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons
    Authors: N.N. Mishra, A.S. Bayer, C. Weidenmaier, T. Grau, S. Wanner, S. Stefani, …
    Year: 2014
    Citations: 141

  • Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: a review of the available evidence
    Authors: S. Stefani, F. Campanile, M. Santagati, M.L. Mezzatesta, V. Cafiso, G. Pacini
    Year: 2015
    Citations: 118

  • Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains
    Authors: V. Cafiso, T. Bertuccio, D. Spina, S. Purrello, F. Campanile, C. Di Pietro, …
    Year: 2012
    Citations: 112

  • Oregano and thyme essential oils encapsulated in chitosan nanoparticles as effective antimicrobial agents against foodborne pathogens
    Authors: G. Granata, S. Stracquadanio, M. Leonardi, E. Napoli, G. Malandrino, …
    Year: 2021
    Citations: 95

  • dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus
    Authors: V. Cafiso, T. Bertuccio, S. Purrello, F. Campanile, C. Mammina, A. Sartor, …
    Year: 2014
    Citations: 80

  • Infections with VIM-1 Metallo-β-Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome
    Authors: M. Falcone, M.L. Mezzatesta, M. Perilli, C. Forcella, A. Giordano, V. Cafiso, …
    Year: 2009
    Citations: 80

  • Molecular and Immunological Characterization of Staphylococcus aureus in Pediatric Atopic Dermatitis: Implications for Prophylaxis and Clinical Management
    Authors: C. Pascolini, J.L. Sinagra, S. Pecetta, V. Bordignon, A. De Santis, L. Cilli, …
    Year: 2011
    Citations: 72

✅ Conclusion

Prof. Viviana Cafiso stands as a pillar of excellence in microbiology, with a research profile that harmoniously blends clinical application and molecular investigation. Her persistent dedication to combating antimicrobial resistance, mentoring young researchers, and contributing to global infectious disease research makes her a deserving nominee for the Best Researcher Award.

Arman Soltani Moghadam | Medicine | Best Researcher Award

Published on by Forensic Scientist

Dr. Arman Soltani Moghadam | Medicine | Best Researcher Award

Tehran Herat Center | Iran

Dr. Arman Soltani Moghadam is a dedicated medical doctor and cardiovascular researcher based in Tehran, Iran. With a strong foundation in clinical medicine and an exceptional academic record, he has significantly contributed to cardiology through both clinical practice and extensive research collaborations internationally. Known for his precision in diagnostics and passion for scientific inquiry, he serves as a General Practitioner while actively engaging in cutting-edge cardiovascular research with institutions such as Tehran University of Medical Sciences and the University of Arizona.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Arman Soltani Moghadam demonstrates a rare blend of clinical expertise, academic excellence, and prolific research productivity at a remarkably early career stage. With dual appointments in top-tier institutions such as Tehran Heart Center and the University of Arizona, he brings international collaboration into practice. His extensive publication record, including meta-analyses in high-impact journals like Journal of the American Heart Association, Clinical Cardiology, and Frontiers in Immunology, underlines his commitment to evidence-based cardiology. His editorial contributions to BMJ and Artificial Organs, as well as multiple conference abstracts presented at AHA and ACC, show active involvement in shaping the scientific dialogue.

Moreover, his ability to work across disciplines—ranging from echocardiography and interventional cardiology to artificial intelligence in medicine—shows a visionary mindset. His numerous certifications from Oxford, Johns Hopkins, and Coursera on clinical trials, machine learning, and statistical methods further reinforce his scientific rigour. Notably, his early leadership as a corresponding author and multiple first-author meta-analyses reflect originality and independence in research.

🎓 Education

Dr. Moghadam earned his Doctor of Medicine (M.D.) diploma from Islamic Azad University, Tehran Medical Sciences Branch (2014–2021), graduating with a commendable GPA of 3.65/4.0. Prior to that, he completed his Diploma in Natural Science at the National Organization for the Development of Exceptional Talents (NODET), where he achieved a perfect GPA of 4.0/4.0. His strong academic foundation reflects his commitment to lifelong learning and excellence in science.

💼 Experience

Currently, Dr. Moghadam works as a General Practitioner at Amiralam Hospital in Tehran, while concurrently contributing as a Research Assistant in the Department of Cardiology at Tehran University of Medical Sciences. He previously served at Chamran Hospital and completed his internship at Islamic Azad University. Additionally, he collaborates remotely with the University of Arizona as a cardiovascular research assistant, showcasing his global engagement in healthcare research.

🔬 Research Interests On Medicine

Dr. Moghadam’s research is rooted in cardiology, with focused interests in interventional cardiology, structural heart disease, electrophysiology, and echocardiography. His studies aim to bridge clinical observations with evidence-based medicine, frequently employing meta-analytical techniques and advanced statistical tools. He is passionate about improving cardiovascular outcomes through innovation and collaboration.

🏆 Awards and Honors

🏅 Ranked 1st in the Clinical Knowledge Exam among his peers, Dr. Moghadam also secured 2nd position based on GPA in his MD program. He is a recognized member of the Iranian Society of Atherosclerosis (IR SA) and actively participates in national and international scientific communities. His commitment to education is evident from his extensive teaching and mentoring experiences.

📄 Publications

  • Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
    Authors: AB Boroumand, M Forouhi, F Karimi, AS Moghadam, LG Naeini, …
    Year: 2022
    Cited by: 58

  • Human diseases Research and textbook 1: Heart, Diabetes, Bacterial, ADHD, skin
    Authors: AT Mohammadi, S Karami, A Jahandideh, S Sarejloo, S Vaseghi, …
    Year: 2022
    Cited by: 29

  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
    Authors: A Vakilpour, E Amini-Salehi, A Soltani Moghadam, MH Keivanlou, …
    Year: 2024
    Cited by: 21

  • Emerging Technologies in Medicine: Artificial Intelligence, Robotics, and Medical Automation
    Authors: M Rezaei, S Saei, SJ Khouzani, ME Rostami, M Rahmannia, …
    Year: 2023
    Cited by: 21

  • In Patients with Cardiogenic Shock, Extracorporeal Membrane Oxygenation Is Associated with Very High All-Cause Inpatient Mortality Rate
    Authors: MR Movahed, A Soltani Moghadam, M Hashemzadeh
    Year: 2024
    Cited by: 1

  • Gender-based Disparity in Performing Aortic Valve Surgery in the United State Before Availability of Percutaneous Valve Implantation
    Authors: MR Movahed, AS Moghadam, M Hashemzadeh, M Hashemzadeh
    Year: 2024
    Cited by: 1

  • Revisiting echocardiographic features of prosthetic heart valves: the necessity of correct differentiation of mono-leaflet vs. bileaflet mechanical heart valves in a case report
    Authors: SHAASM Farnoosh Larti’t, Babak Geraiely’t
    Year: 2024
    Cited by: 1

  • Intravascular Lithotripsy Versus Rotational Atherectomy in the Management of Calcific Coronary Lesions: A Systematic Review and Meta‐Analysis
    Authors: AS Moghadam, N Kakavand, FO Shirmard, A Poopak, N Anaraki, …
    Year: 2025
    Cited by: Not available

  • Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Trials
    Authors: K Tavakoli, NSH Mohammadi, P Bahiraie, S Saeidi, F Shaker, …
    Year: 2025
    Cited by: Not available

  • Time Trend Analysis of Clinical Outcomes for Drug-Coated Balloon versus Drug-Eluting Stent among Patients with Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Trials
    Authors: A Soltani Moghadam, S Kazemian, S Shojaei, Saman Soltani Moghadam, …
    Year: 2024
    Cited by: Not available

✅ Conclusion

Dr. Arman Soltani Moghadam exemplifies the fusion of clinical acumen and research innovation. With a diverse portfolio of international collaborations, high-impact publications, and a continuous pursuit of academic and clinical excellence, he stands as a strong nominee for any global medical or research award. His contributions not only enhance cardiovascular knowledge but also inspire the next generation of physician-scientists.

Prabhat Singh | Pharmacology | Excellence in Research

Published on by Forensic Scientist

Dr. Prabhat Singh | Neuroscience | Excellence in Research

Faculty of Pharmacy, Swami Vivekanand Subharti University | India

Dr. Prabhat Singh, a seasoned academic and researcher in the field of Pharmacology, currently serves as an Associate Professor at Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut. Born on July 8, 1988, Dr. Singh holds a B. Pharm., M. Pharm. (Pharmacology), and a Ph.D. His passion lies in advancing pharmaceutical education and scientific R&D. His academic dedication and research acumen have established him as a prominent figure in neuropharmacological research.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Prabhat Singh demonstrates a consistent and impactful research trajectory in the field of Neuropharmacology, Vascular Dementia, and Physiological Brain Conditioning. With over 22 peer-reviewed publications, several in high-impact journals such as Neurochemical Research, Current Neurovascular Research, and Central Nervous System Agents in Medicinal Chemistry, his work reflects both depth and innovation.

  • He has published research with a total international impact factor exceeding 31.8, an h-index of 9, and over 300 citations, highlighting growing academic recognition.

  • His exploration of novel pharmacological targets in ischemia-reperfusion brain injury and morphine withdrawal syndromes represents translational value in therapeutic strategies.

  • Dr. Singh has contributed significantly to scholarly literature through book publications (4 authored books), book chapters (3 in Nova Science Publishers, USA), and 6 IPRs on innovative healthcare technologies, including AI-powered medication systems and neurodegenerative disease detection devices.

  • As a Ph.D. supervisor to six scholars and mentor to eight M.Pharm students, he has actively nurtured the next generation of pharmaceutical researchers.

🎓 Education

Dr. Singh completed his Ph.D. in Pharmacology from Dr. APJ Abdul Kalam Technical University, Lucknow in 2022. He earned his M. Pharm. from Mahamaya Technical University, Noida with an impressive 81.78% in 2013 and his B. Pharm. from Uttar Pradesh Technical University in 2011 with 73.19%. His foundational education was completed under the Uttar Pradesh Board, achieving consistent academic performance. He is also a GPAT qualifier (2011) and actively contributes to university committees.

👨‍🏫 Experience

Dr. Singh has over a decade of teaching experience. Since February 2023, he has been working as an Associate Professor at Kharvel Subharti College of Pharmacy. Previously, he served as Assistant Professor at the same institution from 2016 to 2023 and at Kalka Institute for Research and Advanced Studies from 2013 to 2016. Additionally, he has industrial experience as a Product Sales Representative with Dr. Reddy’s Laboratories. He has guided 08 M. Pharm theses and is currently supervising 06 Ph.D. scholars.

🔬 Research Interests On Pharmacology

Dr. Singh’s research interests are deeply rooted in Neuropharmacology, with specific focus on vascular dementia, neurotoxicity, and physiological brain conditioning. His doctoral research involved novel pharmacological interventions during experimental ischemia-reperfusion brain injury. His work integrates behavioral neuroscience and biochemical analysis to explore therapeutic pathways in brain disorders.

🏆 Awards & Achievements

Dr. Singh is a committed academic with a strong track record of publication and intellectual property. He has authored four books, contributed to multiple book chapters published by Nova Science Publishers, and published six IPRs including innovations in AI-based medication systems and neurodegenerative disease detection devices. His cumulative journal impact factor exceeds 31.8, with an h-index of 9 and over 300 citations.

📚 Publications

  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    Authors: S Gupta, P Singh, B Mohan Sharma, B Sharma
    Year: 2015
    Citations: 73

  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    Authors: P Singh, S Gupta, B Sharma
    Year: 2015
    Citations: 45

  • Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular …
    Authors: S Gupta, B Sharma, P Singh, B Mohan Sharma
    Year: 2014
    Citations: 40

  • Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
    Authors: S Gupta, P Singh, B Sharma
    Year: 2016
    Citations: 26

  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 …
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 25

  • Selective serotonin-norepinephrine re-uptake inhibition limits renovascular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 23

  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Authors: P Singh, B Sharma, S Gupta, BM Sharma
    Year: 2015
    Citations: 22

  • Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb
    Authors: SG Prabhat Singh, Vipin K Garg, Pramod K Sharma
    Year: 2012
    Citations: 13

  • Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
    Authors: Anshika, RK Pandey, L Singh, S Kumar, P Singh, M Pathak, S Jain
    Year: 2022
    Citations: 12

  • Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition
    Authors: P Singh, S Gupta, B Sharma
    Year: 2016
    Citations: 12

🧩 Conclusion

Dr. Prabhat Singh exemplifies academic excellence and research innovation in pharmacological sciences. With deep engagement in neuropharmacology, substantial teaching contributions, groundbreaking IPRs, and impactful publications, he continues to push the frontiers of pharmaceutical research and education. His commitment to scientific inquiry and student mentorship makes him a highly deserving candidate for this prestigious research award.

Hasan Hallaçeli | Medicine | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Hasan Hallaçeli | Medicine | Best Researcher Award

Hatay Mustafa Kemal University | Turkey

Prof. Dr. Hasan Hallaçeli is a distinguished Turkish physiotherapist and academician specializing in orthopedic rehabilitation. A 1989 graduate of Hacettepe University with a Ph.D. earned in 1996, he is currently serving at Hatay Mustafa Kemal University, Faculty of Medicine. With a visionary approach, he has pioneered the establishment of orthopedic physiotherapy departments in four university hospitals across Turkey. As an honorary member of the Turkish Orthopaedics and Traumatology Association, he has devoted his career to enhancing postoperative rehabilitation, especially for knee, shoulder, and elbow surgeries. Passionate about education and service, he has supervised 10 master’s theses and contributed to over 100 scientific outputs, while actively volunteering in combat sports and for children with disabilities.

Professional profile👤

Google Scholar

Scopus

Strengths for the Awards✨

  • Extensive Academic Background: Ph.D. in Physiotherapy (1996); graduated from Hacettepe University, a top institution in Turkey.

  • Institution Building: Established orthopaedic physiotherapy departments in four university hospitals across Turkey.

  • Research Contributions:

    • Over 100 scientific publications including:

      • 11 SCI-indexed journal articles

      • 19 international/national refereed journal papers

      • 19 book chapters

      • 55 conference presentations

  • Editorial Roles: Editor of three specialized books in orthopaedic physiotherapy.

  • Book Publications:

    • Ortopedik Fizyoterapi ve Rehabilitasyon (2021)

    • Ortopedik Fizyoterapi – Diz (2020)

    • Physiotherapy And Rehabilitation in Knee Joint Extensor Mechanism (2022)

🎓 Education

Dr. Hallaçeli graduated from Hacettepe University’s Faculty of Physiotherapy and Rehabilitation in 1989. He pursued his academic aspirations further and obtained a Ph.D. in 1996. His academic journey reflects a strong foundation in clinical expertise and theoretical rigor, setting the stage for his future innovations in orthopedic physiotherapy.

💼 Experience

Prof. Hallaçeli has held influential academic positions across Turkey, playing a key role in the foundation of orthopedic physiotherapy units in multiple universities. With vast clinical experience, he focuses on rehabilitation following orthopedic surgeries, especially in high-impact joints. His clinical skills, combined with over three decades of academic leadership, have significantly shaped the field in both practice and policy.

🔬 Research Interests On Medicine

His research interests center on orthopedic physiotherapy—particularly the rehabilitation of the shoulder, elbow, and knee—and extend into sports injuries in combat sports. Dr. Hallaçeli also conducts multidisciplinary studies on postural balance and fall risk among patients with knee osteoarthritis and post-prosthetic surgery. His work aims to improve patient safety and athletic performance through scientific insights.

🏆 Awards

Prof. Hallaçeli is recognized as an Honorary Member of the Turkish Orthopaedics and Traumatology Association for his notable contributions to the field. In addition to academic leadership, his dedication to community services—especially for disabled children and combat sports athletes—has further solidified his reputation as a compassionate and impactful professional.

📚 Publications

  • The effect of combined therapy (spa and physical therapy) on pain in various chronic diseases
    A Cimbiz, V Bayazit, H Hallaceli, U Cavlak
    📅 2005 | 📑 73 citations

  • Normal hip, knee and ankle range of motion in the Turkish population
    H Hallaceli, V Uruç, HH Uysal, R Özden, Ç Hallaçeli, F Soyuer, T Parpucu, …
    📅 2014 | 📑 72 citations

  • Importance of anatomy education in physical therapy and rehabilitation in Turkey: A qualitative study
    F Duman, I Huzmeli, B Yucekaya, H Hallaceli, M Gunes
    📅 2017 | 📑 18 citations

  • Normal range of scapular elevation and depression in healthy subjects
    H Hallaceli, I Günal
    📅 2002 | 📑 13 citations

  • A new anchor augmentation technique with a cancellous screw in osteoporotic rotator cuff repair: an in vitro biomechanical study on sheep humerus specimens
    V Uruc, R Ozden, Y Dogramacı, A Kalacı, H Hallaceli, F Küçükdurmaz
    📅 2014 | 📑 12 citations

  • Goniometric Measurements of the Angular Values of the Joints in the Fore-and Hindlimbs of Kangal Dogs
    S Ates, C Hallaceli, H Hallaceli, I Kürtül
    📅 2011 | 📑 11 citations

  • Does scapular elevation accompany glenohumeral abduction in healthy subjects?
    H Hallaceli, M Manisali, I Gunal
    📅 2004 | 📑 11 citations

  • Türk toplumunda kalça diz ve ayak bileğinin normal eklem hareket açıklığı
    H Hallaçeli, V Uruç, HH Uysal, R Özden, Ç Hallaçeli, F Soyuer, …
    📅 2014 | 📑 10 citations

  • Injuries in wheelchair basketball players
    ED Huzmeli, N Katayifci, H Hallaceli
    📅 2017 | 📑 8 citations

  • A new clinical design measuring the vertical axial rotation through tibial shaft resulting from passive knee and subtalar joints rotation in healthy subjects: A reliability study
    A Cımbız, U Cavlak, M Sarı, H Hallaceli, F Beydemir
    📅 2006 | 📑 8 citations

🔚 Conclusion

In conclusion, Prof. Dr. Hasan Hallaçeli’s career embodies excellence in orthopedic physiotherapy, scholarly publishing, and community engagement. With over three decades of dedicated academic, clinical, and volunteer service, he continues to inspire through innovation and empathy. His interdisciplinary focus—bridging rehabilitation, sports, and education—makes him a deserving candidate for any prestigious recognition.

Yang-Xin Fu | Immunology | Best Researcher Award

Published on by Forensic Scientist

Prof. Yang-Xin Fu | Immunology | Best Researcher Award

Tsinghua University | China

Dr. Yang-Xin Fu is a distinguished physician-scientist renowned for his groundbreaking contributions to immunology and cancer research. With an impressive H-factor of 105 and over 41,000 citations, he stands among the top 0.1% of most-cited scientists globally. His illustrious career spans several prestigious institutions, including the University of Chicago, UT Southwestern, and currently, Tsinghua University, where he serves as an Endowed Professor and Director of the Cancer Center. Dr. Fu’s work has profoundly impacted our understanding of lymphoid tissue development, immune cell interactions, and innovative strategies for cancer immunotherapy. He is recognized for his pioneering efforts in harnessing the immune system to combat cancer, focusing on how local interventions, such as radiation, can synergize with immunotherapy to achieve systemic anti-tumor effects.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Yang-Xin Fu is internationally recognized as a pioneering figure in immunology and oncology. With an H-index of 105 and over 41,000 citations, he ranks in the top 0.1% of cited scientists globally, underscoring his immense influence on the scientific community. His groundbreaking work in tumor immunology, particularly in cancer immunotherapy and immune modulation in the tumor microenvironment, has led to paradigm-shifting discoveries.

Key strengths include:

  • Academic Excellence: Educated at prestigious institutions including the University of Miami and Washington University, Dr. Fu blends deep clinical knowledge with scientific innovation.

  • Global Leadership: Holding senior academic and research leadership roles at institutions like the University of Chicago, UT Southwestern, and now Tsinghua University, where he is Director of the Cancer Center.

  • Research Prowess: His publications have appeared in top-tier journals including Nature Immunology, Cancer Cell, Science Immunology, and Immunity.

  • Mentorship: Trained over 50 graduate students and postdoctoral fellows, many of whom are now faculty or researchers at globally respected institutions.

  • Editorial Roles & Peer Recognition: Editorial duties in journals like Journal of Immunology and Cancer Immunology Research, and reviewer for leading journals and funding agencies worldwide.

  • Prestigious Positions: He is a fellow or member of multiple elite societies including AAAS, AACR, and the American Association of Immunologists.

Education 🎓

Dr. Fu’s extensive educational journey laid a strong foundation for his scientific endeavors. He began his medical training at Shanghai Medical University (1978-1983) and completed an internship and residency in Allergy at Peking Union Medical College Hospital (1982-1986). Driven by a passion for research, he pursued his Ph.D. in Microbiology and Immunology at the University of Miami School of Medicine (1986-1990) under the mentorship of Dr. Diana M. Lopez. Following his doctoral studies, he undertook postdoctoral training in Infectious Disease at the National Jewish Center for Immunology and Respiratory Medicine (1991-1993) with Dr. Willi Born, and further honed his skills during a residency in Laboratory Medicine at Washington University (1994-1998), mentored by David Chaplin. This comprehensive training provided him with a unique blend of clinical expertise and deep immunological knowledge.

Experience 🔬

Dr. Fu’s professional trajectory showcases a steady rise to leadership and significant academic influence. He joined the University of Chicago in 1998 as an Assistant Professor in the Department of Pathology and Committee on Immunology, quickly becoming a full member of the Cancer Center in 2000 and achieving direct promotion to Tenured Professor in 2005. His dedication to academic excellence was further recognized with the Fanny L. Pritzker Professorship at the University of Chicago in 2015. Concurrently, he expanded his impact as a Senior Investigator of CPRIT and Professor of Pathology and Immunology at UT Southwestern, where he also held the Mary Nell and Ralph B. Rogers Professorship. Since 2021, he has been an Endowed Professor at Tsinghua University, Beijing, and in 2023, he assumed the directorship of the Cancer Center at Tsinghua Medical School, spearheading cutting-edge cancer research and treatment initiatives. His extensive teaching responsibilities across these institutions underscore his commitment to mentoring the next generation of scientists and clinicians.

Research Interest On Immunology 🔍

Dr. Fu’s primary research interests lie at the intersection of immunology and cancer biology, particularly focusing on the intricate mechanisms governing anti-tumor immunity. His work delves into understanding how lymphoid tissues develop and function, the role of various immune cells in health and disease, and the development of novel immunotherapeutic strategies. A significant aspect of his research investigates the synergy between local interventions, such as radiation therapy, and systemic immunotherapy to enhance anti-tumor responses and overcome treatment resistance. He explores how radiation-induced DNA damage in tumor cells can trigger innate DNA-sensing pathways in dendritic cells, thereby improving T-cell priming and systemic immunity. Furthermore, his lab investigates the potential of novel antibody-based therapies, including anti-CD47 antibodies and LIGHT fusion proteins, to activate and expand tumor-infiltrating lymphocytes and convert “cold” tumors into “hot” immune-responsive ones.

Awards 🏆

Dr. Yang-Xin Fu has received numerous accolades throughout his distinguished career, recognizing his significant contributions to medical science. His early promise was acknowledged with the Howard Hughes Medical Institute Fellowship for Physician Scientists in 1991 and consecutive Young Investigator Awards from ACLPS in 1996 and 1997. He further secured a prestigious Clinical Investigator Award (K08) from NIAID in 1997 and an NMSS Awardee in 1999. His international stature was highlighted by his appointment as Guest Professor and Adviser in the Chinese Academy of Sciences in 2005. More recently, in 2015, he was honored with Endowed Professorships at both the University of Chicago and UT Southwestern, and received the Senior Investigator Award from CPRIT, underscoring his sustained impact and leadership in the field.

Publication 📝

Dr. Fu’s prolific publication record is a testament to his extensive research contributions, with over 41,000 citations and an H-factor of 105, placing him among the top 0.1% of most-cited scientists. A comprehensive list of his publications can be found on his NCBI profile and Google Scholar.

  • Innate and adaptive immune cells in the tumor microenvironment
    Authors: TF Gajewski, H Schreiber, YX Fu
    Year: 2013
    Citations: 4295

  • Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
    Authors: L Deng, H Liang, B Burnette, M Beckett, T Darga, RR Weichselbaum, et al.
    Year: 2014
    Citations: 2162

  • STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors
    Authors: L Deng, H Liang, M Xu, X Yang, B Burnette, A Arina, XD Li, H Mauceri, et al.
    Year: 2014
    Citations: 1990

  • Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
    Authors: Y Lee, SL Auh, Y Wang, B Burnette, Y Wang, Y Meng, M Beckett, et al.
    Year: 2009
    Citations: 1485

  • Radiotherapy and immunotherapy: a beneficial liaison?
    Authors: RR Weichselbaum, H Liang, L Deng, YX Fu
    Year: 2017
    Citations: 1004

  • Commensal bacteria protect against food allergen sensitization
    Authors: AT Stefka, T Feehley, P Tripathi, J Qiu, K McCoy, SK Mazmanian, et al.
    Year: 2014
    Citations: 962

  • The efficacy of radiotherapy relies upon induction of type I interferon–dependent innate and adaptive immunity
    Authors: BC Burnette, H Liang, Y Lee, L Chlewicki, NN Khodarev, et al.
    Year: 2011
    Citations: 936

  • The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells
    Authors: J Qiu, JJ Heller, X Guo, ZE Chen, K Fish, YX Fu, L Zhou
    Year: 2012
    Citations: 921

  • A STING-activating nanovaccine for cancer immunotherapy
    Authors: M Luo, H Wang, Z Wang, H Cai, Z Lu, Y Li, M Du, G Huang, C Wang, et al.
    Year: 2017
    Citations: 870

  • Phagocytosis checkpoints as new targets for cancer immunotherapy
    Authors: M Feng, W Jiang, BYS Kim, CC Zhang, YX Fu, IL Weissman
    Year: 2019
    Citations: 821

Conclusion 🌟

Dr. Yang-Xin Fu’s career exemplifies a profound dedication to advancing human health through rigorous scientific inquiry and innovative translational research. From his foundational work on lymphoid tissue development to his pioneering efforts in cancer immunotherapy, his contributions have significantly broadened our understanding of immune responses and paved the way for novel therapeutic strategies. As an accomplished educator and mentor, he has shaped the careers of numerous aspiring scientists and clinicians. His current leadership role at Tsinghua University’s Cancer Center further solidifies his commitment to combating cancer on a global scale. Dr. Fu’s legacy is marked not only by his exceptional publication record and numerous accolades but also by his enduring impact on the fields of immunology and oncology, promising continued advancements in the fight against disease.

Qianghua Lv | Medicine | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Qianghua Lv | Medicine | Best Researcher Award

Shandong Academy of Agricultural Sciences | China

Dr. Qianghua LV is an Associate Researcher at the Institute of Animal Science and Veterinary Medicine (IASVM), Shandong Academy of Agricultural Sciences (SAAS). He earned his Ph.D. in Veterinary Pharmacology under the mentorship of Prof. DENG Xuming at Jilin University in 2020. His research focuses on developing novel therapeutic strategies targeting bacterial virulence factors, including bacterial hemolysin, Type III Secretion System (T3SS), and Type IV Pili (TFP). His work contributes significantly to understanding anti-infective mechanisms and advancing new drug development against bacterial infections.

Profile👤

ORCID

Strengths for the Awards✨

  • High-Impact Research Focus – Dr. LV Qianghua’s work on anti-infection mechanisms and natural compound-based drug development aligns with global health priorities, particularly in combating superbacterial infections. His research on bacterial virulence factors like hemolysin, T3SS, and TFP contributes to the development of novel antimicrobial strategies.

  • Quality Publications in Reputable Journals – He has multiple first-author and co-first-author publications in high-impact journals, such as Journal of Cellular and Molecular Medicine and Applied Microbiology and Biotechnology. These papers focus on novel antibacterial mechanisms and natural product inhibitors, demonstrating both innovation and scientific rigor.

  • Translational Impact – His research not only advances basic microbiology but also holds significant translational potential in developing new antibacterial therapies, an area of urgent medical need due to rising antibiotic resistance.

  • Collaborative and Multi-Disciplinary Approach – His collaborations with researchers across multiple disciplines (pharmacology, microbiology, and veterinary medicine) enhance the applicability of his findings beyond veterinary science, benefiting both animal and human health.

  • Contribution to Veterinary Medicine – As an Associate Researcher at the IASVM, SAAS, Dr. LV contributes significantly to veterinary pharmacology, a field essential for both agricultural and public health. His work has implications for livestock disease management and food safety, making it highly relevant for both academia and industry.

🎓 Education

  • Ph.D. in Veterinary Pharmacology, Jilin University, 2020
    • Advisor: Prof. DENG Xuming
    • Research Focus: Anti-infection mechanisms of natural compounds targeting bacterial virulence factors

💼 Experience

  • Associate Researcher, IASVM, SAAS (2020–Present)
    • Conducting research on antibacterial strategies targeting virulence factors
    • Screening natural compounds for inhibitory effects on bacterial infections
    • Developing new therapeutic agents against superbacterial infections

🔬 Research Interests On Medicine

  • 🦠 Discovery and screening of novel targets and lead compounds against superb acterial infections
  • 💊 Synergistic antibacterial effects and mechanisms of natural compounds and antimicrobial agents

📚 Selected Publications

  • Title: Inhibition of the type III secretion system by syringaldehyde protects mice from Salmonella enterica serovar Typhimurium
    Authors: Lv Q(#), Chu X(#), Yao X, Ma K, Zhang Y*, Deng X*
    Publication Year: 2019
    Journal: Journal of Cellular and Molecular Medicine

  • Title: Identification of the natural product paeonol derived from peony bark as an inhibitor of the Salmonella enterica serovar Typhimurium type III secretion system
    Authors: Lv Q(#), Li S(#), Wei H, Wen Z, Wang Y, Tang T, Wang J, Xia L*, Deng X*
    Publication Year: 2020
    Journal: Applied Microbiology and Biotechnology

  • Title: Phloretin potentiates polymyxin E activity against Gram-negative bacteria
    Authors: Du R(#), Lv Q(#), Hu W, Hou X, Zhou Y, Deng X, Sun L, Li L, Deng Y, Wang J
    Publication Year: 2021
    Journal: Life Sciences

  • Title: Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection
    Authors: Zhou Y, Liu B, Chu X, Su J, Xu L, Li L, Deng X, Li D*, Lv Q*, Wang J*
    Publication Year: 2022
    Journal: Communications Biology

  • Title: Isoflavone glucoside genistin, an inhibitor targeting Sortase A and Listeriolysin O, attenuates the virulence of Listeria monocytogenes in vivo and in vitro
    Authors: Liu M(#), Lv Q(#), Xu J, Liu B, Zhou Y, Zhang S, Shen X, Wang L
    Publication Year: 2023
    Journal: Biochemical Pharmacology

🔚 Conclusion

Dr. LV Qianghua has dedicated his research to developing innovative antibacterial strategies, focusing on targeting bacterial virulence factors. His contributions in natural compound screening and new drug development have advanced the fight against superbacterial infections. With numerous impactful publications and ongoing research, he continues to make significant strides in veterinary medicine and pharmacology.